膜性肾病生物标志物的研究进展
Advances in Biomarkers of Membranous Nephropathy
DOI: 10.12677/ACM.2023.131067, PDF,    科研立项经费支持
作者: 唐钰书：川北医学院第二临床学院南充市中心医院肾内科，四川 南充；谢席胜*：川北医学院第二临床学院南充市中心医院肾内科，四川 南充；慢性肾脏病基础与临床研究南充市重点实验室，四川 南充
关键词: 膜性肾病；生物标志物；诊断分类；Membrane Nephropathy； Biomarkers； Diagnostic Classification
摘要: 特发性膜性肾病(idiopathic membranous nephropathy, IMN)是一种常见的免疫性肾脏疾病，是成人终末期肾病的重要病因之一。及时诊断、规范治疗和定期随访关乎患者预后。关于M型磷脂酶A2受体和1型血小板反应蛋白7A域在IMN发病机制中的研究日趋完善，对IMN的临床诊疗产生了重要影响。随着中性内肽酶、外泌素1和外泌素2、神经源性表皮生长因子样分子1、信号素3B、神经细胞黏附分子1、III型转化生长因子β受体、原钙粘蛋白7、丝氨酸蛋白酶高温重组蛋白1、网织蛋白G1、原钙粘蛋白FAT1、接触素1等新的生物标志物相继被发现，MN精准诊疗的潜在靶点不断丰富。本文就上述生物标志物的特点、临床意义及最新进展进行综述。
Abstract: Idiopathic membranous nephropathy (IMN) is a common immune kidney disease and one of the important causes of adult end-stage renal disease. Timely diagnosis, standardized treatment and regular follow-up are related to the prognosis of patients. The research on the pathogenesis of MN of M-type phospholipase A2 receptor and Thrombospondin type-1 domain-containing 7A has become increasingly perfect, which has an important impact on the clinical diagnosis and treatment of IMN. Along with neutral endopeptidase, Exostosin 1/Exostosin 2, Neural epidermal growth factor-like 1 proteinhave, Semaphorin 3B, Neural cell adhesion molecule 1, Transforming Growth Factor Beta Receptor 3, Protocadherin 7, high-temperature requirement A serine peptidase 1, Netrin G1, Pro-tocadherin FAT1, and contactin-1 have been found, and the potential targets for accurate diagnosis and treatment of MN are increasingly enriched. This article reviews the characteristics, clinical sig-nificance and recent progress of the above biomarkers.
文章引用：唐钰书, 谢席胜. 膜性肾病生物标志物的研究进展[J]. 临床医学进展, 2023, 13(1): 442-451. https://doi.org/10.12677/ACM.2023.131067

参考文献

[1] Couser, W.G. (2017) Primary Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 983-997. [Google Scholar] [CrossRef] 
[2] Ronco, P., Plaisier, E. and Debiec, H. (2021) Advances in Membranous Nephropathy. Journal of Clinical Medicine, 10, 607. [Google Scholar] [CrossRef] [PubMed]
[3] Lai, W.L., Yeh, T.H., Chen, P.M., et al. (2015) Membranous Nephropathy: A Review on the Pathogenesis, Diagnosis, and Treatment. Journal of the Formosan Medical Association, 114, 102-111. [Google Scholar] [CrossRef] [PubMed]
[4] Ruggenenti, P., Fervenza, F.C. and Remuzzi, G. (2017) Treatment of Membranous Nephropathy: Time for a Paradigm Shift. Nature Reviews Nephrology, 13, 563-579. [Google Scholar] [CrossRef] [PubMed]
[5] Xu, X., Wang, G., Chen, N., et al. (2016) Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China. Journal of the American Society of Nephrology, 27, 3739-3746. [Google Scholar] [CrossRef] 
[6] Zhu, P., Zhou, F.D., Wang, S.X., et al. (2015) Increasing Fre-quency of Idiopathic Membranous Nephropathy in Primary Glomerular Disease: A 10-Year Renal Biopsy Study from a Single Chinese Nephrology Centre. Nephrology (Carlton), 20, 560-566. [Google Scholar] [CrossRef] [PubMed]
[7] Alsharhan, L. and Beck Jr., L.H. (2021) Membranous Nephropathy: Core Curriculum 2021. American Journal of Kidney Diseases, 77, 440-453. [Google Scholar] [CrossRef] [PubMed]
[8] Beck Jr., L.H., Bonegio, R.G., Lambeau, G., et al. (2009) M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 361, 11-21. [Google Scholar] [CrossRef] 
[9] Tomas, N.M., Beck Jr., L.H., Meyer-Schwesinger, C., et al. (2014) Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 371, 2277-2287. [Google Scholar] [CrossRef] 
[10] Debiec, H., Guigonis, V., Mougenot, B., et al. (2002) Antenatal Membranous Glomerulonephritis Due to Anti-Neutral Endopeptidase Antibodies. The New England Journal of Medicine, 346, 2053-2060. [Google Scholar] [CrossRef] 
[11] Sethi, S., Madden, B.J., Debiec, H., et al. (2019) Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 30, 1123-1136. [Google Scholar] [CrossRef] 
[12] Sethi, S., Debiec, H., Madden, B., et al. (2020) Neural Epidermal Growth Factor-Like 1 Protein (NELL-1) Associated Membranous Nephropathy. Kidney International, 97, 163-174. [Google Scholar] [CrossRef] [PubMed]
[13] Sethi, S., Debiec, H., Madden, B., et al. (2020) Semaphorin 3B-Associated Membranous Nephropathy Is a Distinct Type of Disease Predominantly Present in Pediatric Patients. Kidney International, 98, 1253-1264. [Google Scholar] [CrossRef] [PubMed]
[14] Caza, T.N., Hassen, S.I., Kuperman, M., et al. (2021) Neural Cell Adhesion Molecule 1 Is a Novel Autoantigen in Membranous Lupus Nephritis. Kidney International, 100, 171-181. [Google Scholar] [CrossRef] [PubMed]
[15] Caza, T.N., Hassen, S.I., Kenan, D.J., Storey, A., Arthur, J.M., et al. (2021) Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous Nephropathy. Kidney360, 2, 1275-1286. [Google Scholar] [CrossRef] 
[16] Sethi, S., Madden, B., Debiec, H., et al. (2021) Protocadherin 7-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 32, 1249-1261. [Google Scholar] [CrossRef] 
[17] Al-Rabadi, L.F., Caza, T., Trivin-Avillach, C., et al. (2021) Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 32, 1666-1681. [Google Scholar] [CrossRef] 
[18] Reinhard, L., Machalitza, M., Wiech, T., et al. (2022) Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 33, 1823-1831. [Google Scholar] [CrossRef] 
[19] Sethi, S., Madden, B., Casal Moura, M., et al. (2022) Hematopoi-etic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1. Journal of the American Society of Nephrology, 33, 1033-1044. [Google Scholar] [CrossRef] 
[20] Le Quintrec, M., Teisseyre, M., Bec, N., et al. (2021) Contactin-1 Is a Novel Target Antigen in Membranous Nephropathy Associated with Chronic Inflammatory Demyelinating Polyneu-ropathy. Kidney International, 100, 1240-1249. [Google Scholar] [CrossRef] [PubMed]
[21] Li, J., Cui, Z., Long, J., et al. (2018) Primary Glomerular Nephrop-athy among Hospitalized Patients in a National Database in China. Nephrology Dialysis Transplantation, 33, 2173-2181. [Google Scholar] [CrossRef] [PubMed]
[22] 王凯. 单中心3899例肾活检患者临床与病理特征分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
[23] Hou, J.H., Zhu, H.X., Zhou, M.L., et al. (2018) Changes in the Spectrum of Kid-ney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China. Kidney Disease (Basel), 4, 10-19. [Google Scholar] [CrossRef] [PubMed]
[24] Nie, S., He, W., Huang, T., et al. (2018) The Spectrum of Biopsy-Proven Glomerular Diseases among Children in China: A National, Cross-Sectional Survey. Clinical Journal of the American Society of Nephrology, 13, 1047-1054. [Google Scholar] [CrossRef] 
[25] 谢志勇, 李志莲, 董伟, 等. 慢性肾小球疾病谱演变和膜性肾病流行病学特点[J]. 临床肾脏病杂志, 2019, 19(7): 471-476+492.
[26] Ponticelli, C. and Passerini, P. (2010) Can Prog-nostic Factors Assist Therapeutic Decisions in Idiopathic Membranous Nephropathy? Journal of Nephrology, 23, 156-163.
[27] Keri, K.C., Blumenthal, S., Kulkarni, V., et al. (2019) Primary Membranous Nephropathy: Comprehen-sive Review and Historical Perspective. Postgraduate Medical Journal, 95, 23-31. [Google Scholar] [CrossRef] [PubMed]
[28] Hofstra, J.M., Fervenza, F.C. and Wetzels, J.F. (2013) Treatment of Idiopathic Membranous Nephropathy. Nature Reviews Nephrology, 9, 443-458. [Google Scholar] [CrossRef] [PubMed]
[29] Jennette, J.C., Iskandar, S.S. and Dalldorf, F.G. (1983) Pathologic Differentiation between Lupus and Nonlupus Membranous Glomerulopathy. Kidney International, 24, 377-385. [Google Scholar] [CrossRef] [PubMed]
[30] Debiec, H., Guigonis, V., Mougenot, B., et al. (2003) Antenatal Mem-branous Glomerulonephritis with Vascular Injury Induced by Anti-Neutral Endopeptidase Antibodies: Toward New Concepts in the Pathogenesis of Glomerular Diseases. Journal of the American Society of Nephrology, 14, S27-S32. [Google Scholar] [CrossRef] 
[31] Debiec, H., Nauta, J., Coulet, F., et al. (2004) Role of Truncating Mutations in MME Gene in Fetomaternal Alloimmunisation and Antenatal Glomerulopathies. The Lancet, 364, 1252-1259. [Google Scholar] [CrossRef] 
[32] Vivarelli, M., Emma, F., Pellé, T., et al. (2015) Genetic Ho-mogeneity but IgG Subclass-Dependent Clinical Variability of Alloimmune Membranous Nephropathy with Anti-Neutral Endopeptidase Antibodies. Kidney International, 87, 602-609. [Google Scholar] [CrossRef] [PubMed]
[33] Hoxha, E., Kneißler, U., Stege, G., et al. (2012) Enhanced Expression of the M-Type Phospholipase A2 Receptor in Glomeruli Cor-relates with Serum Receptor Antibodies in Primary Membranous Nephropathy. Kidney International, 82, 797-804. [Google Scholar] [CrossRef] [PubMed]
[34] Beck Jr., L.H. and Salant, D.J. (2010) Membranous Nephropathy: Recent Travels and New Roads Ahead. Kidney International, 77, 765-770. [Google Scholar] [CrossRef] [PubMed]
[35] Ronco, P. and Debiec, H. (2014) Anti-Phospholipase A2 Receptor Antibodies and the Pathogenesis of Membranous Nephropa-thy. Nephron Clinical Practice, 128, 232-237. [Google Scholar] [CrossRef] [PubMed]
[36] Hofstra, J.M., Beck Jr., L.H., Beck, D.M., et al. (2011) Anti-Phospholipase A₂ Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 6, 1286-1291. [Google Scholar] [CrossRef] 
[37] Brglez, V., Boyer-Suavet, S., Zorzi, K., et al. (2020) Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial. Frontiers in Medi-cine (Lausanne), 7, 412. [Google Scholar] [CrossRef] [PubMed]
[38] Seitz-Polski, B., Dolla, G., Payré, C., et al. (2016) Epitope Spread-ing of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. Journal of the American Society of Nephrology, 27, 1517-1533. [Google Scholar] [CrossRef] 
[39] KDIGO (2021) Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International, 100, S1-S276. [Google Scholar] [CrossRef] [PubMed]
[40] Xian, L., Dong, D., Luo, J., et al. (2019) Expression of THSD7A in Neoplasm Tissues and Its Relationship with Proteinuria. BMC Nephrology, 20, 332. [Google Scholar] [CrossRef] [PubMed]
[41] Hoxha, E., Wiech, T., Stahl, P.R., et al. (2016) A Mechanism for Cancer-Associated Membranous Nephropathy. The New England Journal of Medicine, 374, 1995-1996. [Google Scholar] [CrossRef] 
[42] Hoxha, E., Beck Jr., L.H., Wiech, T., et al. (2017) An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. Journal of the American Society of Nephrology, 28, 520-531. [Google Scholar] [CrossRef] 
[43] Sharma, S.G. and Larsen, C.P. (2018) Tissue Staining for THSD7A in Glomeruli Correlates with Serum Antibodies in Primary Membranous Nephropathy: A Clinicopathological Study. Modern Pathology, 31, 616-622. [Google Scholar] [CrossRef] [PubMed]
[44] Wang, G., Sun, L., Dong, H., et al. (2021) Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients. Clinical Journal of the American Society of Nephrology, 16, 727-735. [Google Scholar] [CrossRef] 
[45] Caza, T.N., Hassen, S.I., Dvanajscak, Z., et al. (2021) NELL1 Is a Target Antigen in Malignancy-Associated Membranous Nephropathy. Kidney International, 99, 967-976. [Google Scholar] [CrossRef] [PubMed]
[46] Fila, M., Debiec, H., Perrochia, H., et al. (2022) Recurrence of An-ti-Semaphorin 3B-Mediated Membranous Nephropathy after Kidney Transplantation. Journal of the American Society of Nephrology, 33, 503-509. [Google Scholar] [CrossRef] 
[47] Busse, M., Feta, A., Presto, J., et al. (2007) Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation. Journal of Biological Chemistry, 282, 32802-32810. [Google Scholar] [CrossRef] 
[48] Iwakura, T., Ema, C., Isobe, S., et al. (2022) Prevalence of Neural Epidermal Growth Factor-Like 1- and Exostosin 1/Exostosin 2-Associated Membranous Nephropathy: A Single-Center Retrospective Study in Japan. Scientific Reports, 12, Article No. 2967. [Google Scholar] [CrossRef] [PubMed]
[49] Wada, Y., Iyoda, M., Suzuki, T., et al. (2021) Immunopatholog-ical Analysis of the Expression of Glomerular Exostosin 1 and Exostosin 2 in Japanese Patients with Lupus Nephritis. Virchows Archiv, 479, 997-1005. [Google Scholar] [CrossRef] [PubMed]
[50] Ward, F. and Bargman, J.M. (2016) Membranous Lupus Ne-phritis: The Same, But Different. American Journal of Kidney Diseases, 68, 954-966. [Google Scholar] [CrossRef] [PubMed]
[51] Iwakura, T., Ema, C., Sato, T., et al. (2021) Primary Membranous Nephropathy with Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases. Kidney Medi-cine, 3, 669-673. [Google Scholar] [CrossRef] [PubMed]
[52] Troxell, M.L., Higgins, J.P. and Kambham, N. (2014) Renal Pa-thology Associated with Hematopoietic Stem Cell Transplantation. Advances in Anatomic Pathology, 21, 330-340. [Google Scholar] [CrossRef] 
[53] Plaisier, E., Not, A., Buob, D., et al. (2021) Contac-tin-1-Associated Membranous Nephropathy: Complete Immunologic and Clinical Remission with Rituximab. Kidney In-ternational, 100, 1342-1344. [Google Scholar] [CrossRef] [PubMed]

为你推荐